Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-16-006925)

Filing Details

Accession Number:: 0001415889-16-006925
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-08-19 16:36:26
Reporting Period:: 2016-08-17

Filing Date:: 2016-08-19
Accepted Time:: 2016-08-19 16:36:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1109196	Mabvax Therapeutics Holdings Inc.	MBVX	Pharmaceutical Preparations (2834)	930987903

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1186120	P Gregory Hanson	C/O Mabvax Therapeutics, Inc. 11535 Sorrento Valley Rd., Suite 400 San Diego CA 92121	Chief Financial Officer, Secr	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-08-17	3,119	$0.00	16,744	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Class A Warrant	Acquisiton	2016-08-17	3,119	$0.00	3,119	$5.55
Common Stock	Class B Warrant	Acquisiton	2016-08-17	3,119	$0.00	3,119	$6.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,119			No	4	P	Direct
3,119			No	4	P	Direct

Footnotes

Reporting Person paid $4.81 to purchase each share of Common Stock together with a Class A Warrant to purchase one share of Common Stock, and a Class B Warrant to purchase one share of Common Stock.
Warrant is immediately exercisable and expires on the third anniversary of its issuance date